Template:Adrenergic receptor modulators: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
en>AlyInWikiWonderland Add butopamine. |
||
| Line 8: | Line 8: | ||
| group1 = [[Alpha-1 adrenergic receptor|α<sub>1</sub>]] | | group1 = [[Alpha-1 adrenergic receptor|α<sub>1</sub>]] | ||
| list1 = | | list1 = {{Navbox|child | ||
* | |||
| group1 = Agonists | |||
| list1 = | |||
* [[6-Fluoronorepinephrine|6-FNE]] | |||
* [[Amidephrine]] | * [[Amidephrine]] | ||
* [[Buspirone]] | * [[Buspirone]] | ||
* [[Cirazoline]] | * [[Cirazoline]] | ||
* [[Corbadrine]] | * [[Corbadrine]] | ||
* [[Deoxyepinephrine|Deoxyepinephrine (epinine, ''N''-methyldopamine)]] | |||
* [[Desglymidodrine]] | * [[Desglymidodrine]] | ||
* [[Dexisometheptene]] | * [[Dexisometheptene]] | ||
* [[Dipivefrine]] | * [[Dipivefrine]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
* [[Droxidopa|Droxidopa ( | * [[Droxidopa|Droxidopa (L-DOPS)]]<!--Prodrug--> | ||
* [[Epinephrine]] | * [[Epinephrine]] | ||
* [[Etilefrine]] | * [[Etilefrine]] | ||
* [[Etilevodopa]]<!--Prodrug--> | * [[Etilevodopa]]<!--Prodrug--> | ||
* [[Ethylnorepinephrine]] | * [[Ethylnorepinephrine]] | ||
* [[Ibopamine]]<!--Prodrug--> | |||
* [[Indanidine]] | * [[Indanidine]] | ||
* [[Isometheptene]] | * [[Isometheptene]] | ||
* [[L-DOPA| | * [[L-DOPA|L-DOPA (levodopa)]]<!--Prodrug--> | ||
* [[Phenylalanine| | * [[Phenylalanine|L-Phenylalanine]]<!--Prodrug--> | ||
* [[Tyrosine| | * [[Tyrosine|L-Tyrosine]]<!--Prodrug--> | ||
* [[Melevodopa]]<!--Prodrug--> | * [[Melevodopa]]<!--Prodrug--> | ||
* [[Metaraminol]] | * [[Metaraminol]] | ||
| Line 41: | Line 44: | ||
* [[Phenylephrine]] | * [[Phenylephrine]] | ||
* [[Phenylpropanolamine]] | * [[Phenylpropanolamine]] | ||
* [[Synephrine]] | * [[Synephrine]] | ||
* [[Tetryzoline]] | * [[Tetryzoline]] | ||
| Line 48: | Line 50: | ||
* [[Xylometazoline]] | * [[Xylometazoline]] | ||
| group2 = Antagonists | |||
* [[ | | list2 = | ||
* [[Abanoquil]] | |||
* [[Ajmalicine]] | * [[Ajmalicine]] | ||
* [[Alfuzosin]] | * [[Alfuzosin]] | ||
* [[Anisodamine]] | * [[Anisodamine]] | ||
* [[ | * [[Anisodine]] | ||
* [[Atiprosin]] | * [[Atiprosin]] | ||
* [[Atypical antipsychotic]]s (e.g., [[brexpiprazole]], [[clozapine]], [[olanzapine]], [[quetiapine]], [[risperidone]]) | * [[Atypical antipsychotic]]s (e.g., [[brexpiprazole]], [[clozapine]], [[olanzapine]], [[quetiapine]], [[risperidone]]) | ||
* [[Benoxathian]] | * [[Benoxathian]] | ||
* [[Beta blocker]]s (e.g., [[adimolol]], [[amosulalol]], [[arotinolol]], [[carvedilol]], [[eugenodilol]], [[labetalol]]) | |||
* [[Buflomedil]] | * [[Buflomedil]] | ||
* [[Bunazosin]] | * [[Bunazosin]] | ||
* [[Corynanthine]] | * [[Corynanthine]] | ||
* [[Dapiprazole]] | * [[Dapiprazole]] | ||
* [[Domesticine]] | * [[Domesticine]] | ||
* [[Doxazosin]] | * [[Doxazosin]] | ||
* [[Ergoline]]s (e.g., [[ergotamine]], [[dihydroergotamine]], [[lisuride]], [[terguride]]) | * [[Ergoline]]s (e.g., [[acetergamine]], [[ergotamine]], [[dihydroergotamine]], [[lisuride]], [[nicergoline]], [[terguride]]) | ||
* [[Etoperidone]] | * [[Etoperidone]] | ||
* [[Fenspiride]] | * [[Fenspiride]] | ||
* [[Hydroxyzine]] | * [[Hydroxyzine]] | ||
| Line 73: | Line 74: | ||
* [[Ketanserin]] | * [[Ketanserin]] | ||
* [[L-765,314]] | * [[L-765,314]] | ||
* [[Meta-Chlorophenylpiperazine|mCPP]] | * [[Meta-Chlorophenylpiperazine|mCPP]] | ||
* [[Mepiprazole]] | * [[Mepiprazole]] | ||
| Line 83: | Line 83: | ||
* [[Neldazosin]] | * [[Neldazosin]] | ||
* [[Niaprazine]] | * [[Niaprazine]] | ||
* [[Niguldipine]] | * [[Niguldipine]] | ||
* [[Pardoprunox]] | * [[Pardoprunox]] | ||
| Line 96: | Line 95: | ||
* [[Quinazosin]] | * [[Quinazosin]] | ||
* [[Quinidine]] | * [[Quinidine]] | ||
* [[Silodosin]] | * [[Silodosin]] | ||
* [[Spegatrine]] | |||
* [[Spiperone]] | * [[Spiperone]] | ||
* [[Talipexole]] | * [[Talipexole]] | ||
| Line 111: | Line 110: | ||
* [[WB-4101]] | * [[WB-4101]] | ||
* [[Zolertine]] | * [[Zolertine]] | ||
}} | |||
| group2 = [[Alpha-2 adrenergic receptor|α<sub>2</sub>]] | | group2 = [[Alpha-2 adrenergic receptor|α<sub>2</sub>]] | ||
| list2 = | | list2 = {{Navbox|child | ||
* | |||
| group1 = Agonists | |||
| list1 = | |||
* [[(R)-3-Nitrobiphenyline]] | |||
* [[4-NEMD]] | * [[4-NEMD]] | ||
* [[6-Fluoronorepinephrine|6-FNE]] | * [[6-Fluoronorepinephrine|6-FNE]] | ||
| Line 120: | Line 123: | ||
* [[Apraclonidine]] | * [[Apraclonidine]] | ||
* [[Brimonidine]] | * [[Brimonidine]] | ||
* [[Clonidine]] | * [[Clonidine]] | ||
* [[Corbadrine]] | * [[Corbadrine]] | ||
* [[Deoxyepinephrine|Deoxyepinephrine (epinine, ''N''-methyldopamine)]] | |||
* [[Detomidine]] | * [[Detomidine]] | ||
* [[Dexmedetomidine]] | * [[Dexmedetomidine]] | ||
| Line 128: | Line 131: | ||
* [[Dipivefrine]] | * [[Dipivefrine]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
* [[Droxidopa|Droxidopa ( | * [[Droxidopa|Droxidopa (L-DOPS)]]<!--Prodrug--> | ||
* [[Etilevodopa]]<!--Prodrug--> | * [[Etilevodopa]]<!--Prodrug--> | ||
* [[Ergotamine]] | * [[Ergotamine]] | ||
* [[Epinephrine]] | * [[Epinephrine]] | ||
| Line 138: | Line 140: | ||
* [[Guanfacine]] | * [[Guanfacine]] | ||
* [[Guanoxabenz]] | * [[Guanoxabenz]] | ||
* [[L-DOPA| | * [[L-DOPA|L-DOPA (levodopa)]]<!--Prodrug--> | ||
* [[Phenylalanine| | * [[Phenylalanine|L-Phenylalanine]]<!--Prodrug--> | ||
* [[Tyrosine| | * [[Tyrosine|L-Tyrosine]]<!--Prodrug--> | ||
* [[Ibopamine]]<!--Prodrug--> | |||
* [[Lofexidine]] | * [[Lofexidine]] | ||
* [[Medetomidine]] | * [[Medetomidine]] | ||
| Line 146: | Line 149: | ||
* [[Methyldopa]] | * [[Methyldopa]] | ||
* [[Mivazerol]] | * [[Mivazerol]] | ||
* [[Moxonidine]] | |||
* [[Naphazoline]] | * [[Naphazoline]] | ||
* [[Norepinephrine]] | * [[Norepinephrine]] | ||
| Line 151: | Line 155: | ||
* [[Phenylpropanolamine]] | * [[Phenylpropanolamine]] | ||
* [[Piperoxan]] | * [[Piperoxan]] | ||
* [[ | * [[PS75]] | ||
* [[Rezatomidine]] | * [[Rezatomidine]] | ||
* [[Rilmenidine]] | * [[Rilmenidine]] | ||
| Line 157: | Line 161: | ||
* [[Talipexole]] | * [[Talipexole]] | ||
* [[Tasipimidine]] | * [[Tasipimidine]] | ||
* [[ | * [[Tetryzoline]] | ||
* [[Tiamenidine]] | * [[Tiamenidine]] | ||
* [[Tizanidine]] | * [[Tizanidine]] | ||
| Line 167: | Line 171: | ||
* [[Xylometazoline]] | * [[Xylometazoline]] | ||
* | | group2 = Antagonists | ||
| list2 = | |||
* [[Pyrimidinylpiperazine|1-PP]] | |||
* [[Adimolol]] | * [[Adimolol]] | ||
* [[Amesergide]] | * [[Amesergide]] | ||
| Line 182: | Line 188: | ||
* [[Fluparoxan]] | * [[Fluparoxan]] | ||
* [[Idazoxan]] | * [[Idazoxan]] | ||
* [[Ketanserin]] | |||
* [[Lisuride]] | |||
* [[Meta-Chlorophenylpiperazine|mCPP]] | * [[Meta-Chlorophenylpiperazine|mCPP]] | ||
* [[Mianserin]] | * [[Mianserin]] | ||
| Line 193: | Line 201: | ||
* [[Rauwolscine]] | * [[Rauwolscine]] | ||
* [[Rotigotine]] | * [[Rotigotine]] | ||
* [[Setiptiline]] | * [[Setiptiline]] | ||
* [[Spegatrine]] | |||
* [[Spiroxatrine]] | * [[Spiroxatrine]] | ||
* [[Sunepitron]] | * [[Sunepitron]] | ||
* [[Terguride]] | |||
* [[Tolazoline]] | * [[Tolazoline]] | ||
* [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[fluphenazine]], [[loxapine]], [[thioridazine]]) | * [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[fluphenazine]], [[loxapine]], [[thioridazine]]) | ||
* [[Yohimbine]] | * [[Yohimbine]] | ||
}} | |||
| group3 = [[β-adrenergic receptor|β]] | | group3 = [[β-adrenergic receptor|β]] | ||
| list3 = | | list3 = {{Navbox|child | ||
* | |||
| group1 = Agonists | |||
| list1 = | |||
* [[Abediterol]] | |||
* [[Alifedrine]] | * [[Alifedrine]] | ||
* [[Amibegron]] | * [[Amibegron]] | ||
| Line 215: | Line 229: | ||
* [[Broxaterol]] | * [[Broxaterol]] | ||
* [[Buphenine]] | * [[Buphenine]] | ||
* [[Butopamine]] | |||
* [[Carbuterol]] | * [[Carbuterol]] | ||
* [[Carmoterol]] | * [[Carmoterol]] | ||
| Line 222: | Line 237: | ||
* [[Corbadrine]] | * [[Corbadrine]] | ||
* [[Denopamine]] | * [[Denopamine]] | ||
* [[Deoxyepinephrine|Deoxyepinephrine (epinine, ''N''-methyldopamine)]] | |||
* [[Dipivefrine]] | * [[Dipivefrine]] | ||
* [[Dobutamine]] | * [[Dobutamine]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
* [[Dopexamine]] | * [[Dopexamine]] | ||
* [[Droxidopa|Droxidopa ( | * [[Droxidopa|Droxidopa (L-DOPS)]]<!--Prodrug--> | ||
* [[Epinephrine]] | * [[Epinephrine]] | ||
* [[Etafedrine]] | * [[Etafedrine]] | ||
| Line 233: | Line 248: | ||
* [[Etilevodopa]]<!--Prodrug--> | * [[Etilevodopa]]<!--Prodrug--> | ||
* [[Ethylnorepinephrine]] | * [[Ethylnorepinephrine]] | ||
* [[Eugenodilol]] | |||
* [[Fenoterol]] | * [[Fenoterol]] | ||
* [[Formoterol]] | * [[Formoterol]] | ||
* [[Hexoprenaline]] | * [[Hexoprenaline]] | ||
* [[Higenamine]] | * [[Higenamine]] | ||
* [[Ibopamine]]<!--Prodrug--> | |||
* [[Indacaterol]] | * [[Indacaterol]] | ||
* [[Isoetarine]] | * [[Isoetarine]] | ||
* [[Isoprenaline]] | * [[Isoprenaline]] | ||
* [[Isoxsuprine]] | * [[Isoxsuprine]] | ||
* [[L-DOPA| | * [[L-DOPA|L-DOPA (levodopa)]]<!--Prodrug--> | ||
* [[Phenylalanine| | * [[Phenylalanine|L-Phenylalanine]]<!--Prodrug--> | ||
* [[Tyrosine| | * [[Tyrosine|L-Tyrosine]]<!--Prodrug--> | ||
* [[Levosalbutamol]] | * [[Levosalbutamol]] | ||
* [[Lubabegron]] | |||
* [[Mabuterol]] | * [[Mabuterol]] | ||
* [[Melevodopa]]<!--Prodrug--> | * [[Melevodopa]]<!--Prodrug--> | ||
| Line 259: | Line 277: | ||
* [[Ractopamine]] | * [[Ractopamine]] | ||
* [[Procaterol]] | * [[Procaterol]] | ||
* [[Reproterol]] | * [[Reproterol]] | ||
* [[Rimiterol]] | * [[Rimiterol]] | ||
| Line 269: | Line 286: | ||
* [[Tretoquinol]] | * [[Tretoquinol]] | ||
* [[Tulobuterol]] | * [[Tulobuterol]] | ||
* [[Vibegron]] | |||
* [[Vilanterol]] | * [[Vilanterol]] | ||
* [[Xamoterol]] | * [[Xamoterol]] | ||
| Line 275: | Line 293: | ||
* [[Zinterol]] | * [[Zinterol]] | ||
* | | group2 = Antagonists | ||
| list2 = | |||
* [[Acebutolol]] | |||
* [[Adaprolol]] | * [[Adaprolol]] | ||
* [[Adimolol]] | * [[Adimolol]] | ||
| Line 390: | Line 410: | ||
* [[Xipranolol]] | * [[Xipranolol]] | ||
}} | |||
| below = | |||
* '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]'' | |||
* ''[[Template:Dopamine receptor modulators|Dopaminergics]]'' | |||
* ''[[Template:Serotonin receptor modulators|Serotonergics]]'' | |||
* ''[[Template:Monoamine reuptake inhibitors|Monoamine reuptake inhibitors]]'' | |||
* ''[[Template:Monoamine releasing agents|Monoamine releasing agents]]'' | |||
* ''[[Template:Monoamine metabolism modulators|Monoamine metabolism modulators]]'' | |||
* ''[[Template:Monoamine neurotoxins|Monoamine neurotoxins]]'' | |||
}}<noinclude> | }}<noinclude> | ||
| Line 399: | Line 426: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
}}</noinclude> | }}</noinclude> | ||
Revision as of 00:33, 27 February 2025
